Send the following on WhatsApp
Continue to Chathttps://nl.marketscreener.com/koers/aandeel/CLOVER-BIOPHARMACEUTICALS-128691300/nieuws/Clover-Biopharmaceuticals-Ltd-kondigt-positieve-voorlopige-Fase-I-resultaten-aan-voor-bivalent-RSV-46429762/?utm_source=whatsapp&utm_medium=social&utm_campaign=share